Literature DB >> 16595102

[Evaluation of the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in primary care: the PREseAP Study].

C Brotons1, D Ariño, I Borrás, F Buitrago, M L González, P Kloppe, D Orozco, J M Pepió, P Rodríguez, A I Rodríguez.   

Abstract

OBJECTIVES: To assess the efficacy of a comprehensive secondary prevention programme to reduce morbidity and mortality in patients who have suffered a cardiovascular (CV) event; to control CV risk factors and prophylactic treatment in order to prevent recurrence; and to improve the quality of life of patients with cardiovascular disease.
DESIGN: Randomised, pragmatic, open clinical trial in primary care.
SETTING: A total of 42 primary care centres of 8 different areas in Spain. PARTICIPANTS: Men and women below 86 years old, diagnosed with coronary disease and/or stroke and/or peripheral vascular disease in the preceding year, and who have no serious or terminal disease. INTERVENTION: Primary care centres will be randomised to following usual care (control group), or to following a comprehensive programme of secondary prevention (intervention group). MAIN MEASUREMENTS: Cardiovascular fatal events, cardiovascular non-fatal events, total mortality and health-related quality of life (SF-36).

Entities:  

Mesh:

Year:  2006        PMID: 16595102     DOI: 10.1157/13086317

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  4 in total

1.  [Secondary prevention of ischaemic cardiopathy in Spain. Quo vadis?].

Authors:  Carles Brotons
Journal:  Aten Primaria       Date:  2006-09-30       Impact factor: 1.137

2.  Lipid-lowering drugs in ischaemic heart disease: a quasi-experimental uncontrolled before-and-after study of the effectiveness of clinical practice guidelines.

Authors:  Rosa Dalmau; Miriam Boira; Carina Aguilar; Carlos López; Dolors Rodríguez; Delicia Gentille; Domingo Bofill; Eduard Diogene; Josep M Pepió
Journal:  BMC Cardiovasc Disord       Date:  2011-08-04       Impact factor: 2.298

Review 3.  Interventions for improving modifiable risk factor control in the secondary prevention of stroke.

Authors:  Bernadeta Bridgwood; Kate E Lager; Amit K Mistri; Kamlesh Khunti; Andrew D Wilson; Priya Modi
Journal:  Cochrane Database Syst Rev       Date:  2018-05-07

4.  Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study.

Authors:  Josep Maria Pepió Vilaubí; Domingo Orozco-Beltrán; Alessandra Queiroga Gonçalves; Dolors Rodriguez Cumplido; Carina Aguilar Martin; Adriana Lopez-Pineda; Vicente F Gil-Guillen; Jose A Quesada; Concepcion Carratala-Munuera
Journal:  Int J Environ Res Public Health       Date:  2018-06-11       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.